Project Grant R56HL169176
Award Date
9/21/24
Completion Date
8/31/26
Dollars Obligated
$620K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
The federal Project Grant award of $621,546.00 was granted on July 20, 2025 by the National Heart Lung and Blood Institute (NHLBI), under the CFDA 93.837 Cardiovascular Diseases Research program. The grant supports research focused on observing the catalytic subunit of cAMP-dependent protein kinase A (PKA-C) at the single molecule level, to understand its role in normal heart function and cardiac disease states. Key objectives include: Engineering a single-walled carbon nanotube field effect...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $668,783 to the University of North Carolina at Chapel Hill to investigate the role of extracellular ion dynamics in regulating cardiac pacemaking. The research aims to define potassium ion concentration as a critical factor underlying entrained automaticity within the sinoatrial node, the heart's natural pacemaker, and identify the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) is providing $427,625.00 to the University of Maryland, Baltimore to investigate the conformational dynamics and regulatory mechanisms of the KCNH family of potassium ion channels. The key objectives are to: Examine the voltage sensor domain and S4 helix of KCNH channels using non-canonical amino acid technology to measure structural changes...
This Project Grant award of $788,513 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research focused on understanding the mechanisms underlying the maintenance of cardiac chamber identity in zebrafish. The research aims to elucidate the genetic pathways and signaling mechanisms that reinforce ventricular cardiomyocyte identity and suppress the transition to an atrial identity. Key objectives include identifying the downstream...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $636,822 to Western University of Health Sciences to conduct research on the cooperative modulation of piezo ion channels, which are essential for sensing mechanical forces in the cardiovascular system. The key research objectives are to: 1) use molecular dynamics simulations to study the interactions between piezo channel structures in...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $634,183 to Loyola University of Chicago to research new mechanisms of cardiac ryanodine receptor (RyR) dysfunction during oxidative stress. The key goals are to: 1) define the molecular mechanisms by which intersubunit cross-linking of RyR activates the channel and disrupts calcium homeostasis during oxidative stress, and 2)...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $498,991.40 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Arkansas. The grant, effective January 2, 2025 through December 31, 2027, will support the development of microphysiological systems to investigate molecular pathways and cardiomyocyte function in response to hypoxic cardiac injury associated with myocardial infarction and ischemia-reperfusion injury. The project aims to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $135,840 to the University of Washington from September 1, 2024 to August 31, 2026. The project will investigate the mechanisms of cardiac contractile dysfunction across multiple scales using a combined computational and experimental platform. Specifically, the work will focus on how structural perturbations to the myosin protein affect its...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $124,411.00 to the University of California, Davis to investigate state-specific drug binding to cardiac ion channels and reveal mechanisms of arrhythmogenesis. The research aims to elucidate the discrepancy in proarrhythmic risk between different drugs that block the HERG potassium channel, a major drug anti-target. Key objectives...
The federal Project Grant award of $673,642 from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research aims to investigate the role of lysosomes in contributing to arrhythmic risk and sudden cardiac death in ischemic heart failure. The primary objectives are to: 1) Determine whether a lysosomal-sarcoplasmic reticulum (SR) microdomain exists in ischemic heart failure; 2) Evaluate whether TRPML1-mediated lysosomal Ca2+ release can trigger SR...